-
V599EB-RAF is an oncogene in melanocytes.
Cancer Res. 2004 Apr 1;64(7):2338-42
PMID: 15059882
-
Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.
Cell Signal. 2006 Aug;18(8):1279-86
PMID: 16305822
-
Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins.
Int J Cancer. 1997 Sep 26;73(1):94-103
PMID: 9334815
-
The regulation of normal melanocyte proliferation.
Pigment Cell Res. 2000 Feb;13(1):4-14
PMID: 10761990
-
Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.
J Invest Dermatol. 2001 Dec;117(6):1483-9
PMID: 11886512
-
BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.
Mol Pharmacol. 2001 May;59(5):965-73
PMID: 11306677
-
Cloning of novel splice variants of mouse mGluR1.
Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):93-103
PMID: 10581402
-
Progressive appearance of pigmentation in amelanotic melanoma lesions.
Pigment Cell Res. 2002 Aug;15(4):282-9
PMID: 12100494
-
Establishment of conditional vectors for hairpin siRNA knockdowns.
Nucleic Acids Res. 2003 Aug 1;31(15):e77
PMID: 12888529
-
The metabotropic glutamate receptors: structure and functions.
Neuropharmacology. 1995 Jan;34(1):1-26
PMID: 7623957
-
Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.
Biochem J. 2001 Nov 1;359(Pt 3):465-84
PMID: 11672421
-
Molecular determinants of metabotropic glutamate receptor signaling.
Trends Pharmacol Sci. 2001 Mar;22(3):114-20
PMID: 11239574
-
Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes.
J Cell Physiol. 2000 Jun;183(3):364-72
PMID: 10797311
-
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
Cancer Res. 2007 Mar 1;67(5):2298-305
PMID: 17332361
-
One-week 96-well soft agar growth assay for cancer target validation.
Biotechniques. 2004 May;36(5):826-8, 830, 832-3
PMID: 15152603
-
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.
Nat Genet. 2005 Oct;37(10):1047-54
PMID: 16142232
-
Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.
Cancer Res. 2003 Feb 15;63(4):756-9
PMID: 12591721
-
Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.
Proc Natl Acad Sci U S A. 1975 Nov;72(11):4435-9
PMID: 172908
-
Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling.
J Biol Chem. 2003 Mar 14;278(11):9790-5
PMID: 12514183
-
MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.
Oncogene. 2000 Sep 21;19(40):4647-59
PMID: 11030154
-
A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth.
Int J Cancer. 1987 Mar 15;39(3):414-8
PMID: 3102392
-
Development of heritable melanoma in transgenic mice.
J Invest Dermatol. 1998 Mar;110(3):247-52
PMID: 9506443
-
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
Nat Genet. 2003 May;34(1):108-12
PMID: 12704387
-
Mutations of the BRAF gene in human cancer.
Nature. 2002 Jun 27;417(6892):949-54
PMID: 12068308
-
Glutamate antagonists limit tumor growth.
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6372-7
PMID: 11331750
-
The non-competitive metabotropic glutamate receptor-1 antagonist CPCCOEt inhibits the in vitro growth of human melanoma.
Oncol Rep. 2007 Jun;17(6):1399-404
PMID: 17487397
-
Activated ras. Yet another player in melanoma?
Am J Pathol. 1996 Sep;149(3):739-44
PMID: 8780377
-
p16(Ink4a) in melanocyte senescence and differentiation.
J Natl Cancer Inst. 2002 Mar 20;94(6):446-54
PMID: 11904317
-
Glutamate signalling in non-neuronal tissues.
Trends Pharmacol Sci. 2001 Apr;22(4):174-81
PMID: 11282417
-
Glutamate signaling in peripheral tissues.
Eur J Biochem. 2004 Jan;271(1):1-13
PMID: 14686914
-
Genetic analysis of the GRM1 gene in human melanoma susceptibility.
Eur J Hum Genet. 2007 Nov;15(11):1176-82
PMID: 17609672
-
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes.
EMBO J. 2000 Jun 15;19(12):2900-10
PMID: 10856235
-
The hallmarks of cancer.
Cell. 2000 Jan 7;100(1):57-70
PMID: 10647931
-
Differential oncogenic potential of activated RAS isoforms in melanocytes.
Oncogene. 2007 Jul 5;26(31):4563-70
PMID: 17297468
-
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth.
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15605-10
PMID: 16230611
-
Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.
J Cell Biol. 1989 Dec;109(6 Pt 1):3115-28
PMID: 2556408
-
Glutamate receptors on human melanocytes regulate the expression of MiTF.
Pigment Cell Res. 2006 Feb;19(1):58-67
PMID: 16420247
-
Glutamate release promotes growth of malignant gliomas.
Nat Med. 2001 Sep;7(9):1010-5
PMID: 11533703